- Presentations
- 3
- Markets
- 1
Selarsdi is a brand of Ustekinumab marketed by Teva Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Ustekinumab
- Brand owner
- Teva Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 130 mg/26 mL injection, 45 mg/0.5 mL injection, 90 mg/1 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Selarsdi 130 mg/26 mL injectionIntravenous Cold chain | Teva Pharmaceuticals | US FDA | Available on request |
| Selarsdi 45 mg/0.5 mL injectionSubcutaneous Cold chain | Teva Pharmaceuticals | US FDA | Available on request |
| Selarsdi 90 mg/1 mL injectionSubcutaneous Cold chain | Teva Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Ustekinumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Selarsdi
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.